Noncardiac inpatient has acute hypertension: Treat or not? A retrospective study found more harm than benefit from treating elevated blood pressure in hospitalized noncardiac patients.

Citation metadata

From: Journal of Family Practice(Vol. 71, Issue 7)
Publisher: Jobson Medical Information LLC
Document Type: Report
Length: 1,559 words
Lexile Measure: 1360L

Document controls

Main content

Article Preview :


Manage blood pressure (BP) elevations conservatively in patients admitted for noncardiac diagnoses, as acute hypertension treatment may increase the risk for acute kidney injury (AKI) and myocardial injury.


C: Based on a single, large, retrospective cohort study. (1)

Rastogi R, Sheehan MM, Hu B, et al. Treatment and outcomes of inpatient hypertension among adults with noncardiac admissions. JAMA Intern Med. 2021;181:345-352.


A 48-year-old man is admitted to your family medicine service for cellulitis after failed outpatient therapy. He has presumed community-acquired methicillin-resistant Staphylococcus aureus infection of the left lower extremity and is receiving intravenous (IV) vancomycin. His BP this morning is 176/98 mm Hg, and the reading from the previous shift was 168/94 mm Hg. He is asymptomatic from this elevated BP. Based on protocol, his nurse is asking about treatment in response to the multiple elevated readings. How should you address the patient's elevated BP, knowing that you will see him for a transition management appointment in 2 weeks?

Elevated BP is common in the adult inpatient setting. Prevalence estimates range from 25% to > 50%. Many factors can contribute to elevated BP in the acute ill ness setting, such as pain, anxiety, medication withdrawal, and volume status. (2,3)

Treatment of elevated BP in outpatients is well researched, with evidence-based guidelines for physicians. That is not the case for treatment of asymptomatic elevated BP in the inpatient setting. Most published guidance on inpatient management of acutely elevated BP recommends IV medications, such as hydralazine or labetalol, although there is limited evidence to support such recommendations. There is minimal evidence for outcomes-based benefit in treating acute elevations of inpatient BP, such as reduced myocardial injury or stroke; however, there is some evidence of adverse outcomes, such as hypotension and prolonged hospital stays. (4-8)

Although the possibility of intensifying antihypertensive therapy for those with known hypertension or those with presumed "new-onset" hypertension could theoretically lead to improved outcomes over the long term, there is little evidence to support this presumption. Rather, there is evidence that intensification of antihypertensive therapy at discharge is linked to short-term harms. This was demonstrated in a propensity-matched veteran cohort that included 4056 hospitalized older adults with hypertension (mean age, 77 years; 3961 men), equally split between those who received antihypertensive intensification at hospital discharge and those who did...

Source Citation

Source Citation   

Gale Document Number: GALE|A722030328